Insider trade

Officer sold ~$1.95M of BLFS shares in the open market

Traded Mar 5, 2026 · Filed Mar 9, 2026

Why it stands out

BioLife Solutions's Chief Quality and Operations sold $1.95M of BioLife Solutions shares. The filing does not indicate a pre-arranged trading plan.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Officer$1M+

Classification

open market sale

Code S — open-market or private sale

Absolute commitment

~$1,952,998

Shares × reported transaction price

Timing vs results

7 days after results of Feb 26, 2026, 63 days before results of May 7, 2026

Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results

Planned / mechanical clue

None found in footnotes

Only flagged when a footnote says so; never inferred

After	Stock	S&P 500	Difference
7 days	+3.9%	−0.9%	+4.8%
30 days	+9.7%	+0.4%	+9.3%
90 days	+39.8%	+9.2%	+30.6%
180 days	+89.5%	+13.1%	+76.4%

Past results only. Not a forecast.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.00 to $20.46, inclusive. The reporting person undertakes to provide to the registrant, any security holder of the registrant, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.